Skip to main content

Conavi Medical Corp(CNVI-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.380
Day High0.415
Open:0.400
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Conavi Medical Corp

Select a category then submit the form to load news
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
Upcoming Meeting Dates - January 26, 2026
Conavi Medical Corp. Announces Closing of $12M Public Offering
Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus  
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights
Novasight™ Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case
Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI
Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&A
Life Sciences Investor Forum: Now Available for Online Viewing
Life Sciences Investor Forum Agenda Announced for June 11th-12th
Conavi Medical Announces New Grant of Stock Options
Conavi Medical’s Novasight Hybrid™ System Named “Product Innovation of the Year” at 2025 Minnesota Manufacturing Awards
Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares
Conavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive Plan
Conavi Medical Corp. Announces Upsize to its Previously Announced Public Offering
Conavi Medical Announces Uplisting to OTCQB Venture Market

Profile

Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.